More News

05 Apr 2007 Boca Pharmacal Receives FDA Approval for Generic Pamine(R) and Pamine(R) Forte Tablets
04 Apr 2007 Pharmexa and Affitech enter into an exclusive license agreement to promote Diabody technology
04 Apr 2007 IMPAX Announces FDA Approval of Generic Corzide
03 Apr 2007 Roche acquires THP to expand its therapeutic antibody research
03 Apr 2007 Novavax Vaccine Provides Robust Immune Response, Pre-Clinical Data Show
03 Apr 2007 Senetek PLC Grants Paid Up License to Valeant Pharmaceuticals
03 Apr 2007 CSL Biotherapies Submits BLA to Introduce Flu Vaccine to U.S. Market
31 Mar 2007 Astellas Licenses RegeneronĀ“s Velocimmune(R) Technology For Discovering Human Monoclonal Antibodies
31 Mar 2007 Takeda to Obtain Development and Commercial Rights
31 Mar 2007 CanBas and Takeda to Sign the Collaboration Agreement
31 Mar 2007 LG Life Sciences and Takeda Announce Collaboration
30 Mar 2007 Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery of GLP-1 and PYY
30 Mar 2007 Baxter Announces Final Phase I/II Data and Initiation of Phase III Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine
30 Mar 2007 Ad hoc: Evotec to Acquire Neuro3d
29 Mar 2007 Oxford BioMedica and Sanofi-Aventis Enter Global Licensing Agreement to Develop and Commercialise TroVax for Cancer
29 Mar 2007 MorphoSys and Astellas Enter Antibody Partnership - Deal Seals MorphoSys's Third Japanese Pharmaceutical Alliance
29 Mar 2007 Wockhardt receives US FDA approval for anti-inflammatory injection
29 Mar 2007 Wockhardt receives US FDA approval for diuretic injection, Second FDA approval in a week
29 Mar 2007 Samaritan Pharma Partners PII HIV Drug to Pharmaplaz; Upfront Payment $10 Million
28 Mar 2007 Seattle Genetics Announces Extension of Antibody-Drug Conjugate Collaboration with Genentech
28 Mar 2007 Taro Receives Tentative Approval for Ciclopirox Topical Solution, 8% (Nail Lacquer) ANDA
28 Mar 2007 BrainCells Inc. and Lundbeck Form CNS Drug Research Collaboration
28 Mar 2007 Acuity Pharmaceuticals and Froptix Corporation Agree to Mergers with Public Shell; New Company to Develop and Market Drugs for Disorders of the Eye
27 Mar 2007 Schering-Plough and Merck to Develop Another New Cholesterol Lowering Medicine
27 Mar 2007 Novartis to launch its own branded version of a leading multiple sclerosis therapy through agreement with Bayer Schering Pharma

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top